Insider Transactions in Q4 2022 at Amylyx Pharmaceuticals, Inc. (AMLX)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2022
|
James M Frates Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+12.0%
|
$30,000
$6.88 P/Share
|